ATRA

6.7095.82%
JS

Jim Sesic

Senior Vice President of Regulatory Affairs

Mr. Jim Sesic is Senior Vice President of Regulatory Affairs of Atara Biotherapeutics, Inc. from May 2025. He is an accomplished senior executive with more than 20 years of US and international regulatory experience leading teams in the pharmaceutical, biotechnological, gene and cell therapy industries before taking over his current role at Atara. Prior to joining Atara, He was an Executive Director at Amgen with responsibilities that defined and built Regulatory CMC capabilities, submission and licensing strategies for all their international market expansion. He also oversaw the regulatory teams that supported all Amgen Manufacturing, QC Testing and CMOs. As the CMC SME, he performed due diligence for acquisitions, facility asset integration and manufacturing network optimization. This position also provided regional support for their acquired generic drug portfolio and the international expansion of the Amgen Biosimilar pipeline. Products supported included hematological, bone and oncological therapies. He spent a brief time at Portola Pharmaceuticals, where he focused on supporting the development and commercialization of novel therapeutics for thrombosis and other hematologic conditions. He also worked over 10 years at Alpha Therapeutics Corporation before they were acquired by Grifols Biologics Inc. In addition to his regulatory leadership roles at this allogeneic, plasma-derivative therapeutic company, Jim held positions in Regulatory Compliance, Quality, Operations, Supply Chain and Procurement. He holds a B.S. in International Business Administration from California State University, Los Angeles and is a California licensed Pharmacist Exemptee.

公司職務